Impact of CMV Therapy With Valganciclovir on Immune Activation and the HIV Viral Load in Semen and Blood

Abstract

Although valganciclovir therapy was associated with reduced HIV and semen CMV levels, these results suggest that the reduced HIV VL was a direct drug effect rather than a CMV antiviral effect or CMV-associated immune alterations.